AIDS experts in the US are about to complete a humiliating U-turn when the
Department of Health and Human Services launches its revised HIV treatment
guidelines in January.
The revisions will underline the need to hold back from using powerful
antiviral drugs until the immune systems of HIV patients show significant signs
of decline. It reflects the view, long held by British doctors, that early use
of currently available drugs may do more harm than good.
Charles Carpenter, associate director of the Brown University AIDS programme,
told a Royal Society of Medicine meeting in London last week: “In retrospect, we…
